PRESS RELEASE
News
-
-
PRESS RELEASE
Lighthouse (Formerly OTA Insight) Wins Four 2024 HotelTechAwards, Reinforcing Leadership in Hospitality Technology
Lighthouse, formerly OTA Insight, has been honored with multiple awards in the travel and hospitality industry, marking the fourth consecutive year of recognition. The company's dedication to innovation, data quality, and customer service has been showcased through its unprecedented success in categories such as Best Rate Shopping & Market Intelligence, Best Hotel Rate Parity, and Best Business Intelligence. The rebranding to Lighthouse in 2023 has introduced new features and reinforced the company's commitment to empowering hoteliers with cutting-edge solutions and insights. Sean Fitzpatrick, the CEO of Lighthouse, expressed immense pride in receiving the awards and emphasized the company's unwavering commitment to excellence and customer success. The Hotel Tech Report Awards, known for acknowledging outstanding technology providers in the global hotel industry, have once again recognized Lighthouse for its exceptional performance. Lighthouse's reputation for rapid innovation and top-tier customer support has solidified its position as a leader in the industry, catering to a diverse range of hoteliers across the globe. -
PRESS RELEASE
ZetrOZ Systems’ sam 2.0 Wearable Ultrasound Unit Receives New FDA Clearance for Expanded Medical Indications
ZetrOZ Systems' sam® 2.0 long-duration wearable ultrasound unit has received clearance from the U.S. Food and Drug Administration for expanded indications to treat soft tissue injuries and knee osteoarthritis, making the sustained acoustic medicine device more accessible to a wider range of medical conditions. The FDA's decision signifies the device's safety and effectiveness, paving the way for increased utilization in both professional sports and general population healthcare. The company's founder and CEO, George K. Lewis, highlights the significance of the FDA clearance, emphasizing the numerous studies demonstrating the technology's efficacy in treating injuries without the need for oral medication, corticosteroids, or surgery. -
PRESS RELEASE
VerityXR Continues to Grow, Kicking-Off 2024 by Hiring Industry Expert Naha Patel, PT, DPT as the New Director of Operations and Business Development
VerityXR, a trailblazer in merging healthcare with cutting-edge technology, proudly announces the strategic hiring of Naha Patel, PT, DPT, as the new Director of Operations and Business Development. Naha Patel's arrival marks a significant milestone in VerityXR's accelerating journey towards redefining healthcare delivery. Learn more about the latest addition to VerityXR's leadership team and their commitment to innovation and operational agility. -
PRESS RELEASE
Quicklly and ZEE5 Global Join Forces to Bring Bollywood and Indian Flavors to Every Household in the US
Quicklly and ZEE5 Global have announced a groundbreaking partnership that will elevate cultural experiences for South Asians in the US. This collaboration aims to provide a unique blend of entertainment and cultural convenience, bringing together the vibrant hues of Bollywood entertainment with the rich and diverse flavors of authentic South Asian cuisine. Quicklly, as the premier online South Asian marketplace, will leverage this collaboration to offer a delightful journey into traditional South Asian cuisine, allowing users to savor their favorite dishes while immersing themselves in the rich tapestry of cultural content offered by ZEE5 Global. -
PRESS RELEASE
Kevin Interdonato Crime Thriller The Bastard Sons Secures North American Distribution With Vertical
Vertical has acquired North American rights to the crime thriller, The Bastard Sons, from writer, director, and star Kevin Interdonato. The film follows a group of small-town gangsters seeking revenge after an inside job leaves their Boss killed. The tale weaves themes of loyalty, revenge, and the strength of chosen family, while showcasing exceptional performances by the cast. Watch The Bastard Sons on Apple iTunes and Amazon Prime Video. -
-
PRESS RELEASE
ALKEME Acquires Flor Insurance Group
ALKEME, a Top 40 Insurance Brokerage, has announced the acquisition of Flor Insurance Group, a leading independent insurance agency specializing in commercial trucking insurance and international freight transportation. This strategic move allows ALKEME to expand their transportation practice and offer more comprehensive solutions to their clients. The acquisition reflects ALKEME's commitment to sustainable growth and success in the rapidly modernizing insurance industry. -
-
REGULATED PRESS RELEASE
NFL BIOSCIENCES: FINANCIAL CALENDAR FOR 2024
NFL Biosciences, a biopharmaceutical company, has announced its financial communication calendar for 2024, including dates for annual results, Annual General Meeting, and half-year results. The company is known for developing botanical drug candidates for the treatment of addictions, such as NFL-101 for nicotine cessation and NFL-301 for reducing alcohol consumption. For more information, visit www.nflbiosciences.com.
